Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hardwin O'dowd is active.

Publication


Featured researches published by Hardwin O'dowd.


Journal of Organic Chemistry | 2011

An Asymmetric Synthesis of (2S,5S)-5-Substituted Azepane-2-Carboxylate Derivatives

Donn G. Wishka; Marion Bedard; Katherine E. Brighty; Richard A. Buzon; Kathleen A. Farley; Michael W. Fichtner; Goss S. Kauffman; Jaap Kooistra; Jason G. Lewis; Hardwin O'dowd; Ivan Samardjiev; Brian Samas; Geeta Yalamanchi; Mark C. Noe

To facilitate a drug discovery project, we needed to develop a robust asymmetric synthesis of (2S,5S)-5-substituted-azepane-2-carboxylate derivatives. Two key requirements for the synthesis were flexibility for elaboration at C5 and suitability for large scale preparation. To this end we have successfully developed a scalable asymmetric synthesis of these derivatives that starts with known hydroxy-ketone 8. The key step features an oxidative cleavage of aza-bicyclo[3.2.2]nonene 14, which simultaneously generates the C2 and C5 substituents in a stereoselective manner.


Archive | 2010

Isoindolinone inhibitors of phosphatidylinositol 3-kinase

Alex Aronov; Jon H. Come; Robert J. Davies; Albert Pierce; Jian Wang; Suganthini Nanthakumar; Jingrong Cao; Upul K. Bandarage; Elaine Krueger; Amaud Le Tiran; Yusheng Liao; David Messersmith; Philip N. Collier; Ronald Grey; Hardwin O'dowd; James A. Henderson; Anne-Laure Grillot


Archive | 2005

Novel lincomycin derivatives possessing antibacterial activity

Jason G. Lewis; Sampath Kumar Anandan; Hardwin O'dowd; Mikhail F. Gordeev; Liansheng Li


Archive | 2012

Pyrimidine gyrase and topoisomerase iv inhibitors

Tiran Arnaud Le; Anne-Laure Grillot; Paul S. Charifson; Youssef L. Bennani; Hardwin O'dowd; Emanuele Perola


Archive | 2012

Phosphate esters of gyrase and topoisomerase inhibitors

Youssef L. Bennani; Paul S. Charifson; Anne-Laure Grillot; Arnaud Letiran; Hardwin O'dowd


Archive | 2013

COMBINATION THERAPY TO TREAT MYCOBACTERIUM DISEASES

Christopher Locher; Youssef L. Bennani; Anne-Laure Grillot; Hardwin O'dowd; Emanuele Perola; Arnaud Le Tiran; Paul S. Charifson


Archive | 2013

SOLID FORMS OF (R)-2-(5-(2-(3-ETHYLUREIDO)-6-FLUORO-7-(TETRAHYDROFURAN-2-YL)-1H-BENZO[D]IMIDAZOL-5-YL)PYRIMIDIN-2-YL)PROPAN-2-YL DIHYDROGEN PHOSPHATE AND SALTS THEREOF

Hardwin O'dowd; Dainius Macikenas; Bin Song


Archive | 2013

Gyrase and topoisomerase iv inhibitors

Arnaud Le Tiran; Anne-Laure Grillot; Paul S. Charifson; Youssef L. Bennani; Hardwin O'dowd; Emanuele Perola


Archive | 2016

A SELECTIVE INHIBITOR OF PHOSPHATIDYLINOSITOL 3-KINASE-GAMMA

Michael J. Boyd; Alex Aronov; Hardwin O'dowd; Jeremy Green


Archive | 2014

Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases

Christopher Locher; Youssef L. Bennani; Anne-Laure Grillot; Hardwin O'dowd; Emanuele Perola; Tiran Arnaud Le

Collaboration


Dive into the Hardwin O'dowd's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alex Aronov

University of Washington

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge